Evidence map›Paper›PMID 38799245›Full record

ArticleF1000Research2023

COVID-19 Vaccine: Predicting Vaccine Types and Assessing Mortality Risk Through Ensemble Learning Algorithms.

Hind Monadhel, Ayad R Abbas, Athraa Jasim Mohammed

Abstract read
In one paragraph

Article in F1000Research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hind MonadhelComputer Science, University of Technology - Iraq, Baghdad, Iraq.ORCID https://orcid.org/0000-0002-9923-4979
Ayad R AbbasComputer Science, University of Technology- Iraq, Baghdad, Iraq.ORCID https://orcid.org/0000-0002-9797-421X
Athraa Jasim MohammedComputer Science, University of Technology- Iraq, Baghdad, Iraq.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: There is no doubt that vaccination is crucial for preventing the spread of diseases; however, not every vaccine is perfect or will work for everyone. The main objective of this work is to predict which vaccine will be most effective for a candidate without causing severe adverse reactions and to categorize a patient as potentially at high risk of death from the COVID-19 vaccine. Methods: A comprehensive analysis was conducted using a dataset on COVID-19 vaccine adverse reactions, exploring binary and multiclass classification scenarios. Ensemble models, including Random Forest, Decision Tree, Light Gradient Boosting, and extreme gradient boosting algorithm, were utilized to achieve accurate predictions. Class balancing techniques like SMOTE, TOMEK_LINK, and SMOTETOMEK were incorporated to enhance model performance. Results: The study revealed that pre-existing conditions such as diabetes, hypertension, heart disease, history of allergies, prior vaccinations, other medications, age, and gender were crucial factors associated with poor outcomes. Moreover, using medical history, the ensemble learning classifiers achieved accuracy scores ranging from 75% to 87% in predicting the vaccine type and mortality possibility. The Random Forest model emerged as the best prediction model, while the implementation of the SMOTE and SMOTETOMEK methods generally improved model performance. Conclusion: The random forest model emerges as the top recommendation for machine learning tasks that require high accuracy and resilience. Moreover, the findings highlight the critical role of medical history in optimizing vaccine outcomes and minimizing adverse reactions.

Indexed as

AlgorithmsCOVID-19COVID-19 VaccinesMachine LearningEnsemble LearningFemaleHumansMaleRisk AssessmentSARS-CoV-2COVID-19 VaccinesClassification algorithmCOVID-19 Vaccineensemble learningmachine learningSampling methodsSide effects.

Identifiers

PMID38799245
PMCPMC11128056

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.